Ï㽶ÊÓƵ

Ìý

Ìý

Researchers at The Neuro are world leaders in cellular and molecular neuroscience, brain imaging, cognitive neuroscience and the study and treatment of neurological diseases and disorders. Here are their stories.

Making progress against MS progression

28 May 2024

Researchers have developed drugs that improve the outlook for millions of patients.

On the hunt for a treatment

25 Apr 2024

The Neuro is launching its first ever clinical trials for Huntington’s Disease.

A more effective means to detect and treat epileptic seizures

15 Apr 2024

Dr. Jeffrey Hall’s research is refining epilepsy surgery to create lesions that permanently disrupt seizures.

Supporting the next generation of autism researchers

5 Apr 2024

The Quebec Autism Research Training program is a competitive program offered by the Azrieli Centre for Autism Research and the Transforming Autism Care Consortium.

Repressing a faulty gene

18 Mar 2024

A study underway at The Neuro is the first in Canada to evaluate whether a treatment using an antisense oligonucleotide therapy would be effective against Creutzfeldt-Jakob Disease.

From piano jazz halls to the neuropsychology lab

15 Feb 2024

Patrick Hewan reflects on the importance of Black History Month and building a more inclusive future in neuroscience.

Tackling the growing burden of neurological disease

24 Jan 2024

Tarun Dua from the WHO says we need to respond to the growing impact of neurological disease on the human population.

Year in review: 2023

21 Dec 2023

2023 was full of exciting developments at The Neuro. Here is a list of our top news stories from the year.

Pages

The Neuro logoÌýMcGill logo

Ìý

The Neuro (Montreal Neurological Institute-Hospital)Ìýis a bilingual academic healthcare institution. We are aÌýMcGill research and teaching institute; delivering high-quality patient care, as part of the Neuroscience Mission of the Ï㽶ÊÓƵ Health Centre.ÌýWe areÌýproud to be a Killam Institution, supported by the Killam Trusts.

Ìý

Ìý

Back to top